Meijia Technology has submitted an IPO prospectus and plans to list in Hong Kong.

CellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy

Endpoints NewsBiopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and more

Science Daily BiotechThe secret language behind animal cooperation

Endpoints NewsEndpoints News History: 10 Years, Bootstrap to FT

Clinical OMICsImproving HSV-2 Vaccine Efficacy with Combination Strategy

CellMultimodal imaging of gene expression, morphology, and activity of the same neuron

10x Genomics News10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics - Zacks Investment Research

FierceBiotechFDA warning slams Zoll Medical with multiple quality control and reporting violations

BioWorldHangzhou Innogate Pharma discovers new KAT inhibitors

BioWorldAlicorn synthesizes new AAK1 inhibitors

BioWorldChinese scientists identify new macrocyclic compounds as kinase inhibitors

BioWorldNew VAV1 degradation inducers reported in Haisco Pharmaceutical Group patents